Systemic metabolic reprogramming and microbial dysbiosis in Fabry disease: Multi-omics mechanisms and implications for drug development. [PDF]
Gómez-Cebrián N +5 more
europepmc +1 more source
How should kidney injury in Fabry disease be assessed and monitored? [PDF]
Song SH.
europepmc +1 more source
Episodic pain in Fabry disease is mediated by a heat shock protein-transient receptor potential cation channel A1 axis. [PDF]
Enders JD +4 more
europepmc +1 more source
Proposed Stages of Myocardial Phenotype Development in Fabry Disease.
S. Nordin +14 more
semanticscholar +1 more source
Therapeutic landscape of Fabry disease: advances and challenges from classical strategies to emerging therapies. [PDF]
Zhang M, Wang C.
europepmc +1 more source
Mutagenesis of Human Alpha-Galactosidase A for the Treatment of Fabry Disease
Erin Stokes
openalex +1 more source
Long-Term Enzyme Replacement Therapy and Renal Outcomes in Fabry Disease: A Systematic Review and Meta-Analysis. [PDF]
Chen CY +6 more
europepmc +1 more source
Cardiac involvement in Anderson–Fabry disease. The role of advanced echocardiography [PDF]
Letìzia Spinelli +4 more
openalex +1 more source
Non-Pulmonary Vein Substrate Ablation of Recurrent Atrial Fibrillation in the Patient With Fabry Disease. [PDF]
Onuki K +5 more
europepmc +1 more source

